Streptozocin

In the US, Streptozocin (streptozocin systemic) is a member of the drug class alkylating agents and is used to treat Pancreatic Cancer.

US matches:

• Streptozocin


• Streptozocin Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01AD04

CAS registry number (Chemical Abstracts Service)

0018883-66-4

Chemical Formula

C8-H15-N3-O7

Molecular Weight

265

Therapeutic Category

Antineoplastic antibacterial

Chemical Name

D-Glucose, 2-deoxy-2-[[(methylnitrosoamino)carbonyl]amino]-

Foreign Names

• Streptozocinum (Latin)
• Streptozocin (German)
• Streptozocine (French)
• Estreptozocina (Spanish)

Generic Names

• Streptozocin (OS: USAN)
• Streptozocine (OS: DCF)
• NRRL 2697 (IS)
• NRRL 3125 (IS)
• Streptozotocin (IS)
• U 9889 (IS: Upjohn)

Brand Names

• Zanosar
  CSP, France; Pfizer, Canada; Pfizer, Switzerland; Pfizer, Israel; Teva USA, United States

International Drug Name Search

Glossary

DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.